Utilizing BioBlocks’ CFL to Identify New IP We’ve found that an enormous amount of new chemical matter is still available for drug discovery using fragment-based methods. BioBlocks has designed our Comprehensive Fragment Library (CFL) specifically to access an expanded medicinal chemistry space. Start screening BioBlocks’ CFL by partnering with us today. Even when starting with […]
Read MoreSOMERSET, N.J. – April 24, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced it plans to invest $5 million in the creation of a new drug development center of excellence (CoE) at its Somerset, New Jersey facility and […]
Read MoreData exchange can be one of the biggest challenges impacting relationships between CROs and sponsors. How does your company overcome this issue and what standards of practice can be followed to mitigate issues? We believe that scientific interpretation and responsible usage of the data are the keys to a successful data sharing practice in […]
Read MoreNew Strategic Partnership: CNBE INRS and Wax-it Histology Services Inc. VANCOUVER, BC AND LAVAL, QC. (April 11, 2018) — Wax-it Histology Services Inc. and CNBE (INRS) are pleased to announce a strategic partnership in the area of contractual research in laboratory animal experimentation and histology analysis services by joining their respective expertise. The new strike force […]
Read More
Why Should You Outsource Your Stability Testing? Avomeen, LLC. Content Suggestions: Why Should You Outsource Your Stability Testing? Stability testing is an essential part of clinical trials, whether you plan to market your product in the U.S. or abroad. Unfortunately, because stability testing involves studying how a product changes over a long period, it’s inherently […]
Read More
BioBlocks’ CFL: Designed for Improved Lead Discovery Screenable compounds in BioBlocks’ newly available Comprehensive Fragment Library (CFL) are selected for their improved chemical and pharmaceutical properties. Unlike traditional fragment screening sets of predominantly flat aromatic compounds, the typical CFL fragment features both aromatic and sp3 character in 15 atoms or less, with >95% containing handles […]
Read MorePATIENT RECRUITMENT: A PERSONALIZED APPROACH April 05, 2018 I recently had the opportunity to visit with a few physicians in Central and Eastern Europe (CEE) and learn about their approach with clinical trials and patient recruitment. For our non-EU clients considering a clinical research in the EU, some differences in patient recruitment may be […]
Read MoreData exchange can be one of the biggest challenges impacting relationships between CROs and sponsors. How does your company overcome this issue and what standards of practice can be followed to mitigate issues? Data exchange is a part of the much broader issue of confidentiality when contracting R&D services. In reality, regardless of the geographic […]
Read More